Has Jamison Harvey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,182 in general payments to Jamison Harvey, MD across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jamison Harvey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jamison Harvey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jamison Harvey, MD

Dermatology · Layton, UTNPI 1225526460

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.8% of the total. Reporting peaked in 2023 at $2,513 and has fallen 96.0% since, to $100 in 2025.

$5,182in general payments, 2019–2025

Across 223 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$609
Sun Pharmaceutical Industries Inc.$428
Sanofi$391
LEO Pharma Inc.$334
Regeneron Healthcare Solutions, Inc.$323
plus $2K from 13 others

What the payments were for

Food & beverage$4,90495%
Education$2785%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	50	$1,287
Johnson & Johnson	21	$609
Sun Pharmaceutical Industries Inc.	16	$428
Sanofi	16	$391
LEO Pharma Inc.	14	$334
Regeneron Healthcare Solutions, Inc.	11	$323
Lilly USA, LLC	16	$275
Dermavant Sciences, Inc.	17	$242
UCB, Inc.	10	$217
Incyte Corporation	9	$188
Novartis	9	$185
E.r. Squibb & Sons, L.L.C.	11	$183
Pfizer	5	$170
Amgen	6	$135
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$88
Journey Medical Corporation	2	$70
Mayne Pharma Commercial LLC	3	$23
Arcutis Biotherapeutics, Inc.	1	$20
Helsinn Therapeutics (U.S.), Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,182 in reported general payments places this provider in the 75th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah →

Medicare billing

Part B allowed, 2024

$123,214

Medicare patients

388

Services billed

1,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira PenAdalimumab	12	$81,641
Dupixent PenDupilumab	19	$81,402
Tacrolimus	29	$5,459
Clobetasol Propionate	84	$3,548
Tretinoin	16	$1,497
Ketoconazole	98	$1,379
Fluorouracil	18	$1,197
Metronidazole	18	$1,080
Triamcinolone Acetonide	89	$1,057
Clindamycin Phosphate	25	$802
Doxycycline Hyclate	21	$583
Minoxidil	19	$341
Mupirocin	47	$335
ValacyclovirValacyclovir Hcl	14	$287
Hydrocortisone	40	$232

Paid to pharmacies, not to this prescriber.

Other dermatology in Layton

Steven NickleLayton$11K
Matthew InnesLayton$6K
Michael MartineauLayton$3K
Bradley NeuenschwanderLayton$3K
Brayden ForbesLayton$2K
Scott CheckettsLayton$2K
Brian WilliamsMidvale$876K
Travis JamesProvidence$437K
Jason HadleyBountiful$294K
Doug Lass ForshaWest Jordan$213K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →